Medical News Observer

• The Vibrating Ingestible BioElectronic Stimulator (VIBES) pill triggers a sense of fullness by stimulating stomach mechanoreceptors, mimicking natural satiety signals.

• In animal studies, VIBES significantly reduced food intake by about 40% and curbed weight gain, showcasing its efficacy.

• This technology could drastically change obesity treatment, offering a less invasive alternative to surgeries and drugs.

Vibrating Ingestible BioElectronic Stimulator (VIBES) pill

MIT engineers developed a new method to combat obesity by creating a feeling of fullness using a VIBES pill. Their research study suggests that if proven safe for human use, this technology could offer a minimally invasive treatment for obesity, providing an alternative to existing pharmacological therapies with fewer side effects. 

The VIBES pill works by activating gastric mechanoreceptors, which are responsible for sensing stomach distension and influencing satiety through vagal signaling. The pill’s luminal vibratory stimulation mimics the mechanical distension of the stomach, triggering a hormonal response similar to that of a fed state. This method has shown significant results in reducing food intake by approximately 40% and minimizing weight gain in swine across 108 meals compared to untreated controls. 

The application of this mechanoreceptor-focused approach offers a promising new avenue for treating patients with nutritional disorders, potentially transforming obesity management by circumventing the need for invasive surgeries and high patient adherence.

Ref: Srinivasan, Shriya S., Amro Alshareef, Alexandria Hwang, Ceara Byrne, Johannes Kuosmanen, Keiko Ishida, Joshua Jenkins, et al. 2023. “A Vibrating Ingestible Bioelectronic Stimulator Modulates Gastric Stretch Receptors for Illusory Satiety.” Science Advances 9 (51): eadj3003. https://doi.org/10.1126/sciadv.adj3003.